This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Scott Tuten Biography and Net Worth

CMO of Danimer Scientific

Scott brings to Danimer Scientific a successful history in international logistics, supply-chain management, transportation, inventory control, operations, sales and warehousing. Prior to entering the field of sustainable biopolymers, he held numerous high-level management positions in sales and operations for a multibillion-dollar transportation company. He also managed multistate territories and divisions for Fortune 500 companies. Scott offers expertise in sales management, strategic planning, operations management and policy implementation. He joined Danimer Scientific in 2006 as vice president of operations and was quickly promoted to senior vice president of operations. Following the company merger in 2014, Scott was appointed chief marketing officer to manage overall sales and marketing. He holds a BBA in logistics and an MBA from Georgia Southern University.

What is Scott Tuten's net worth?: The estimated net worth of Scott Tuten is at least $278,984.09 as of June 20th, 2023. Mr. Tuten owns 346,478 shares of Danimer Scientific stock worth more than $278,984 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Tuten may own. Additionally, Mr. Tuten receives an annual salary of $381,640.00 as CMO at Danimer Scientific. Learn More about Scott Tuten's net worth.
How old is Scott Tuten?: Mr. Tuten is currently 48 years old. There are 7 older executives and no younger executives at Danimer Scientific. The oldest executive at Danimer Scientific is Mr. Anthony L. Austin, Chief Human Resource Officer, who is 66 years old. Learn More on Scott Tuten's age.
What is Scott Tuten's salary?: As the CMO of Danimer Scientific, Inc., Mr. Tuten earns $381,640.00 per year. There are 2 executives that earn more than Mr. Tuten. The highest earning executive at Danimer Scientific is Mr. Stephen E. Croskrey, CEO & Chairman of the Board, who commands a salary of $887,940.00 per year. Learn More on Scott Tuten's salary.
How do I contact Scott Tuten?: The corporate mailing address for Mr. Tuten and other Danimer Scientific executives is 774A Walker Rd, Great Falls VA, 22066. Danimer Scientific can also be reached via phone at 229-243-7075 and via email at [email protected]. Learn More on Scott Tuten's contact information.
Has Scott Tuten been buying or selling shares of Danimer Scientific?: Scott Tuten has not been actively trading shares of Danimer Scientific during the last ninety days. Most recently, Scott Tuten sold 10,000 shares of the business's stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $2.74, for a transaction totalling $27,400.00. Following the completion of the sale, the chief marketing officer now directly owns 346,478 shares of the company's stock, valued at $949,349.72. Learn More on Scott Tuten's trading history.
Are insiders buying or selling shares of Danimer Scientific?: During the last twelve months, Danimer Scientific insiders bought shares 1 times. They purchased a total of 50,000 shares worth more than $47,000.00. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 20,000 shares worth more than $61,200.00. The most recent insider tranaction occured on November, 28th when Director Richard J Hendrix bought 50,000 shares worth more than $47,000.00. Insiders at Danimer Scientific own 14.3% of the company. Learn More about insider trades at Danimer Scientific.
Information on this page was last updated on 11/28/2023.

Scott Tuten Insider Trading History at Danimer Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/20/2023	Sell	10,000	$2.74	$27,400.00	346,478
5/17/2023	Sell	10,000	$3.38	$33,800.00	356,478
4/17/2023	Sell	10,000	$4.26	$42,600.00	365,210
3/17/2023	Sell	10,000	$2.10	$21,000.00	375,210
2/17/2023	Sell	10,000	$2.21	$22,100.00	385,210
1/17/2023	Sell	10,000	$2.14	$21,400.00	395,210
12/19/2022	Sell	10,000	$1.63	$16,300.00	424,136
11/17/2022	Sell	10,000	$2.68	$26,800.00	434,136
10/17/2022	Sell	10,000	$2.46	$24,600.00	444,136
9/19/2022	Sell	10,000	$3.58	$35,800.00	454,136
8/17/2022	Sell	10,000	$5.06	$50,600.00	464,136
7/18/2022	Sell	10,000	$5.08	$50,800.00	474,136
6/17/2022	Sell	10,000	$3.79	$37,900.00	484,136
3/17/2022	Sell	10,000	$4.50	$45,000.00
1/18/2022	Sell	10,000	$6.20	$62,000.00
12/17/2021	Sell	10,000	$8.87	$88,700.00
11/17/2021	Sell	10,000	$15.54	$155,400.00
10/18/2021	Sell	10,000	$13.92	$139,200.00
9/17/2021	Sell	10,000	$16.56	$165,600.00
8/17/2021	Sell	10,000	$14.73	$147,300.00

Scott Tuten Buying and Selling Activity at Danimer Scientific

Danimer Scientific Company Overview

Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.

Today's Range

Now: $0.79

$0.77

$0.82

50 Day Range

MA: $1.14

$0.77

$1.70

2 Week Range

Now: $0.79

$0.60

$3.56

Volume

215,104 shs

Average Volume

1,018,532 shs

Market Capitalization

$90.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.51

This Apple-like Innovator is Revolutionizing Healthcare

From Wall Street Star | Ad